• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR SUPERA PERIPHERAL STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR SUPERA PERIPHERAL STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM Back to Search Results
Catalog Number S-50-040-120-P6
Medical Device Problem Codes Material Separation (1562); Patient-Device Incompatibility (2682)
Health Effect - Clinical Code Foreign Body In Patient (2687)
Date of Event 06/20/2019
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Exemption number e2019001 permits numbering sequence to begin with 10000, to avoid duplication of report numbers due to process transition.There may be gaps in numbering for reports submitted during the transition period.The stent remains in the patient.Investigation is not yet complete.A follow up report will be submitted with all relevant information.Na.
 
Event or Problem Description
It was reported that the procedure was performed to treat a lesion in the calcified, chronic totally occluded, superficial femoral artery.The artery was prepared per the instructions for use and with atherectomy.The 5x40mm supera self-expanding stent system (sess) was advanced and the stent was deployed; however, the stent did not fully appose to the vessel wall due to plaque and calcium.During removal of the sess under fluoroscopy, the tip of the nose cone separated.The nose cone remains in the patient anatomy and no treatment was performed.There was no clinically significant delay in the procedure.No additional information was provided.
 
Additional Manufacturer Narrative
Visual analysis was performed on the returned device.The reported tip detachment was confirmed.The stent not apposing to the vessel wall could not be confirmed as it was based on procedural circumstances.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history revealed no indication of a lot specific product issue.The investigation was unable to determine a cause for the reported difficulties.There is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.Exemption number e2019001 permits numbering sequence to begin with 10000, to avoid duplication of report numbers due to process transition.There may be gaps in numbering for reports submitted during the transition period.Correction: expiration date.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SUPERA PERIPHERAL STENT SYSTEM
Common Device Name
SELF EXPANDING PERIPHERAL STENT SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key8786033
Report Number2024168-2019-10053
Device Sequence Number1668657
Product Code NIP
UDI-Device Identifier08717648211737
UDI-Public08717648211737
Combination Product (Y/N)N
Initial Reporter StateKS
Initial Reporter CountryUS
PMA/510(K) Number
P120020
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2019
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 10/14/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date05/31/2020
Device Catalogue NumberS-50-040-120-P6
Device Lot Number8061961
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/13/2019
Initial Date Received by Manufacturer 06/21/2019
Supplement Date Received by Manufacturer09/30/2019
Initial Report FDA Received Date07/12/2019
Supplement Report FDA Received Date10/14/2019
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
6F SHEATH; 6F SHEATH
Outcome Attributed to Adverse Event Other;
Patient Age67 YR
Patient Weight79
-
-